Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy

NCT07629817 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1044

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab + Nab-paclitaxel + Platinum-based Chemotherapy
COMBINATION_PRODUCT: Radiation with Concurrent Chemotherapy
PROCEDURE: Radical Esophagectomy

Sponsor

Henan Cancer Hospital